2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 1 - 5 of 5 drug pricing articles
How Much Does Keytruda Cost with Insurance in the U.S.? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost with Insurance in the U.S.?

33 views

In 2026, most patients pay between $300 and $3,000 per month depending on their plan, deductible, and location. This complete guide breaks down Keytruda prices with and without insurance, Medicare coverage, patient assistance programs, and expert insights to help Americans save on cancer treatment costs.

How Much Does Keytruda Cost in the US in 2025? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost in the US in 2025?

217 views

How Much Does Keytruda Cost in the US in 2025? Price per Dose, Monthly Cost, and Insurance Coverage Updated: October 1, 2025 Keytruda (pembrolizumab) remains one of the most prescribed immunotherapy treatments for cancers such as melanoma, non-small cell lung cancer, and head and neck cancers. But for patients and families, the most pressing question is often: “How much does Keytruda cost in the US in 2025?” In this guide, we break down the latest Keytruda prices per dose, monthly treatment costs, and annual expenses. We also compare prices from leading sources like GoodRx , Drugs.com , and SingleCare to help you understand the current landscape. Beyond raw prices, we explain how insurance coverage, Medicare, and manufacturer assistance programs can dramatically reduce out-of-pocket costs. If you or a loved one are exploring treatment with Keytruda, this resource provides the most up-to-date 2025 information to help you plan financially and discuss options with your healthcare provider.

Keytruda Cost in 2025: Real Monthly Price, Insurance Coverage & Patient Tips - 2026 Drug Cost Analysis

Keytruda Cost in 2025: Real Monthly Price, Insurance Coverage & Patient Tips

145 views

Keytruda (pembrolizumab) is one of the most widely prescribed immunotherapy drugs for cancer — but its high cost often leaves patients wondering how much they will actually pay. In 2025, the average list price for a single Keytruda infusion is around $11,000–$12,000, with annual costs exceeding $190,000 before insurance. Fortunately, Medicare, Medicaid, and private insurers cover most of these expenses, and copay assistance programs can reduce patient costs to as little as $25 per infusion. This guide explains the real monthly price of Keytruda in 2025, how insurance coverage works, and practical tips patients can use to lower out-of-pocket expenses.

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025? - 2026 Drug Cost Analysis

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025?

229 views

In 2025, the cost of Opdivo (Nivolumab) in the United States continues to be a major concern for cancer patients and families. With monthly expenses ranging from $12,000 to $26,000 without insurance, many wonder how they can afford this life-saving immunotherapy. This article explains the true price of Opdivo in 2025, how much insurance covers, available patient assistance programs, and how Opdivo compares to other cancer treatments like Keytruda and Yervoy. You’ll also find updated FAQs with trusted links to help patients make informed financial and medical decisions.

Keytruda Price Per Infusion in USA | Updated 2025 Guide - 2026 Drug Cost Analysis

Keytruda Price Per Infusion in USA | Updated 2025 Guide

328 views

If you or a loved one is considering immunotherapy, understanding the real cost of treatment is crucial. In 2025, the price of Keytruda (pembrolizumab) per infusion in the USA remains a major factor for patients, caregivers, and healthcare providers. On average, a single infusion can cost between $9,800 and $11,500, depending on insurance coverage, treatment duration, and hospital charges. This updated guide explores the latest Keytruda prices, available financial assistance programs, and key insurance considerations to help you plan more effectively. You’ll also find official resources, FAQs, and expert insights, making this one of the most comprehensive guides to Keytruda treatment costs in the USA today.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings